BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3541824)

  • 1. Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect.
    Gengo FM; Huntoon L; McHugh WB
    Arch Intern Med; 1987 Jan; 147(1):39-43. PubMed ID: 3541824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum concentrations and central nervous system actions of metoprolol.
    Gengo FM; Ermer JC; Carey C; Kalonaros GC; McHugh WB
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):101-6. PubMed ID: 3981166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.
    Walle PO; Westergren G; Dimenäs E; Olofsson B; Albrektsen T
    J Clin Pharmacol; 1994 Jul; 34(7):742-7. PubMed ID: 7929868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effects of beta-adrenoceptor antagonists.
    Salem SA; McDevitt DG
    Clin Pharmacol Ther; 1983 Jan; 33(1):52-7. PubMed ID: 6848299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of beta-blockers on mental performance on older hypertensive patients.
    Gengo FM; Fagan SC; de Padova A; Miller JK; Kinkel PR
    Arch Intern Med; 1988 Apr; 148(4):779-84. PubMed ID: 3281618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
    Westerlund A
    Eur J Clin Pharmacol; 1985; 28 Suppl():73-6. PubMed ID: 2865153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease.
    Airaksinen KE; Niemelä MJ; Huikuri HV
    Eur Heart J; 1994 Nov; 15(11):1482-5. PubMed ID: 7835362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.
    Ellis ME; Hussain M; Webb AK; Barker NP; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):59S-64S. PubMed ID: 6743475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-blockade on heart rate variability in patients with coronary artery disease.
    Niemelä MJ; Airaksinen KE; Huikuri HV
    J Am Coll Cardiol; 1994 May; 23(6):1370-7. PubMed ID: 8176095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism.
    Kirch W; Spahn H; Kitteringham NR; Hutt HJ; Mutschler E; Ohnhaus EE
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):65S-68S. PubMed ID: 6743476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS-related side-effects with metoprolol and atenolol.
    Cove-Smith JR; Kirk CA
    Eur J Clin Pharmacol; 1985; 28 Suppl():69-72. PubMed ID: 4054193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and beta-blockers: influence of body fat on their kinetics and cardiovascular effects.
    Galletti F; Fasano ML; Ferrara LA; Groppi A; Montagna M; Mancini M
    J Clin Pharmacol; 1989 Mar; 29(3):212-6. PubMed ID: 2723107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of repeated administration of atenolol and captopril in healthy volunteers.
    McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
    Eur J Clin Pharmacol; 1994; 46(1):23-8. PubMed ID: 8005182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
    Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
    Cardiologia; 1982; 27(8):753-63. PubMed ID: 6765444
    [No Abstract]   [Full Text] [Related]  

  • 19. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-blockers on plasma lipids.
    Pasotti C; Zoppi A; Capra A; Rebagliati M; Fogari R
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.